Ocular nocardia infections with special emphasis on the cornea.
Nocardia are aerobic, gram-positive, nonmotile and branching filamentous bacteria. Corneal infection by Nocardia is rare. Trauma is the most common predisposing factor. Isolated case reports of nocardial infection associated with contact lens wear and laser in situ keratomileusis (LASIK) have been reported. The clinical picture usually consists of superficial patchy infiltrates, which may be arranged in a wreath pattern. Presence of gram-positive, branching, beaded filaments that stain with 1% acid-fast stain (using 1% sulfuric acid, modified Kinyoun's method) in smears of corneal scrapings is suggestive of nocardial infection. Nocardia grow on commonly used media as tiny, white, dry colonies. Available knowledge and clinical experience suggest that although sulfacetamide eyedrops can be tried as the initial drug, trimethoprim-sulfamethoxazole and amikacin are effective drugs. Once therapy is initiated, the infiltrate responds promptly and resolves, forming a corneal scar with or without vascularization, and good visual recovery can be expected.
Cornea Center, L.V. Prasad Eye Institute, Hyderabad, India.
M S
MS
Sridhar
U
U
Gopinathan
P
P
Garg
S
S
Sharma
G N
GN
Rao
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003315:Cornea / Q000382:microbiology / Q000473:pathology*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003937:Diagnosis, Differential; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007634:Keratitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D007637:Keratoconjunctivitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D009615:Nocardia / Q000302:isolation & purification*; D009617:Nocardia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D009883:Ophthalmic Solutions; D011379:Prognosis; D013409:Sulfacetamide / Q000008:administration & dosage; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D013409:Sulfacetamide; D014295:Trimethoprim; D013420:Sulfamethoxazole